News

Exercise pumps up chemotherapy completion rates for breast cancer patients


 

References

Compared with usual care, a moderate- to high-intensity exercise intervention had beneficial effects on chemotherapy completion rates, symptom burden, and return-to-work rates among women with breast cancer who were undergoing adjuvant chemotherapy, according to a study published online April 27 in the Journal of Clinical Oncology.

For the multicenter Physical Exercise During Adjuvant Chemotherapy Effectiveness Study (PACES), 230 women (mean age 51 years) with breast cancer who were undergoing adjuvant chemotherapy were randomized to participate in a high- to moderate-intensity exercise program supervised by physical therapists (n = 76), a low-intensity home-based program (n = 77), or the usual care group (n = 77).

©Luka8au/thinkstockphotos.com

Dose adjustments in the chemotherapy regimen were less frequent in the moderate- to high-intensity exercise group (12%) than in the usual care or low-intensity groups (both 34%, P = .002). Patients in the exercise interventions were more likely to return to work by the 6-month follow up than those with usual care, wrote Ms. Hanna van Waart, a doctoral candidate at the Netherlands Cancer Institute, Amsterdam, and colleagues (J. Clin. Oncol. 2015 Apr. 27 [doi:10.1200/JCO.2014.59.1081]).

“This not only has financial implications, but also carries meaning in terms of quality of life and a sense of return to normalcy,” they wrote.

At completion of chemotherapy, patients from both activity groups reported significantly better physical functioning, less nausea and vomiting, and less pain than did those in the usual care group.

Recommended Reading

Gynecologic cancers predict coexisting pelvic floor disorders
MDedge ObGyn
Vaccine pioneer begins reign as acting director of the National Cancer Institute
MDedge ObGyn
False-positive mammograms cost $2.8 billion a year
MDedge ObGyn
High rates of oophorectomy documented in premenopausal women
MDedge ObGyn
Type, location of BRCA mutations influence risk
MDedge ObGyn
Worse melanoma outcomes found in pregnant women
MDedge ObGyn
HPV-targeted TILs trigger CR in some advanced cervical cancer patients
MDedge ObGyn
Task Force: Start biennial mammograms at age 50
MDedge ObGyn
Class of 2015: New drugs projected to earn billions and billions
MDedge ObGyn
PD-L1 blockade breaks through triple-negative breast cancer
MDedge ObGyn